rs13217795 — FOXO3

The Original FOXO3 Longevity Discovery — Isoform Regulation at the Heart of the Haplotype

In 2008, Bradley Willcox and colleagues published what became the most influential longevity genetics paper of the decade. Scanning insulin/IGF-1 pathway genes in 3,741 Japanese American men enrolled in the Honolulu Heart Program, they identified three variants in FOXO3A simultaneously associated with extreme longevity: rs2764264, rs2802292, and rs13217795. The OR for homozygous minor vs. major alleles was 2.75¹¹ The OR for homozygous minor vs. major alleles was 2.75
Willcox BJ et al. FOXO3A genotype is strongly associated with human longevity. Proc Natl Acad Sci USA. 2008, and men with the longevity genotype showed healthier cardiovascular profiles, lower cancer rates, and better metabolic function.

Of the three discovery variants, rs13217795 has received the least independent mechanistic attention — until recently. Frankum et al. 2022²² Frankum et al. 2022
Extreme longevity variants at the FOXO3 locus may moderate FOXO3 isoform levels. Geroscience. 2022 demonstrated that the C allele at rs13217795 is specifically associated with a shift in FOXO3 isoform balance: more full-length FOXO3 protein, and fewer truncated isoforms that lack a complete forkhead DNA-binding domain. This provides a molecular explanation for how this regulatory variant, sitting in FOXO3's intron, could influence longevity — not by changing how much FOXO3 is made, but by changing what kind is made.

The Mechanism

rs13217795 sits in intron 2 of FOXO3 (intron 5 in some transcript annotations) at chromosome 6 position 108,652,895 on GRCh38. It is part of the same haplotype block as rs2802292 and rs2764264 — the three variants travel together in populations but are not in complete linkage disequilibrium, each capturing some independent information.

The mechanistic focus for this specific variant centers on the FOXO3-TR isoform: a 5' truncated form of FOXO3 that lacks the amino-terminal transactivation domain and part of the forkhead DNA-binding domain. FOXO3-TR can be expressed from an alternative promoter embedded within intron 2 — and rs13217795 maps to the regulatory region controlling this alternative transcription start site.

Frankum et al. found that in skeletal muscle tissue (where FOXO3-TR is expressed at detectable levels, unlike blood), carriers of the C allele showed significantly reduced FOXO3-TR isoform levels compared to TT homozygotes. Because FOXO3-TR lacks a complete forkhead domain, it cannot bind target DNA and activate the downstream programs that underlie FOXO3's protective functions — antioxidant gene induction, autophagy, DNA repair, and attenuation of NF-κB inflammatory signaling. The shift away from FOXO3-TR toward full-length functional FOXO3 in C-allele carriers therefore tilts the cellular balance toward effective stress resistance.

This mechanism is distinct from the other FOXO3 longevity variants: rs2802292 creates an HSF1 binding site that amplifies FOXO3 transcription under stress, while rs2764264 disrupts an NKX3 repressor binding site. rs13217795 operates through a third axis — isoform composition rather than transcription level — providing partially independent contribution to the overall FOXO3 longevity architecture.

The Evidence

The association evidence for rs13217795 is well-replicated. A meta-analysis of 11 independent studies³³ A meta-analysis of 11 independent studies
Bao JM et al. Association between FOXO3A gene polymorphisms and human longevity: a meta-analysis. Asian J Androl. 2014 covering 5,241 long-lived cases and 5,724 controls found the minor allele associated with OR = 1.27 (95% CI 1.10–1.46, p = 0.001). Unlike rs2764264 (which shows male-specific effects) and rs2802292 (which shows the strongest effect in males but replicates in mixed-sex cohorts), rs13217795 shows associations across both sexes in the meta-analysis.

Soerensen et al. 2010⁴⁴ Soerensen et al. 2010
Replication of an association of variation in the FOXO3A gene with human longevity using both case-control and longitudinal data. Aging Cell. 2010 confirmed rs13217795 in Danish oldest-old (the 1905 birth cohort, n=1,089) vs. middle-aged controls (n=736), with the variant remaining significant after multiple-testing correction in males under a recessive model (corrected p = 0.025).

Replication has spanned Chinese nonagenarians and centenarians He et al. 2014⁵⁵ He et al. 2014
FOXO3 variant confirmed in 567 Chinese long-lived individuals vs 508 controls; p=0.0075 codominant model. Aging (Albany NY). 2014, and Northern Indian elderly Hussain et al. 2022⁶⁶ Hussain et al. 2022
C allele associated with lower fasting glucose, insulin, HOMA-IR, CRP, TNF-α, and IL-6 in elderly North Indian patients. Mol Syndromol. 2022, confirming that the longevity signal at rs13217795 extends beyond the original Japanese American discovery population.

The metabolic dimension is particularly actionable. In the Hussain 2022 study, CC homozygotes with diabetes showed significantly lower fasting plasma glucose (FPG), insulin resistance (HOMA-IR), and inflammatory markers (TNF-α, CRP) compared to TT homozygotes — suggesting the C allele's protective isoform shift translates into measurable metabolic advantages relevant to the diabetes-longevity connection.

Practical Actions

The isoform mechanism of rs13217795 has a clear lifestyle correlate. FOXO3-TR expression is regulated by nutrient signaling: high insulin/IGF-1 states (caloric excess, metabolic syndrome, chronic hyperinsulinemia) tend to suppress full-length FOXO3 in favor of alternative promoter usage. C allele carriers already have a genetic bias toward less FOXO3-TR — but TT homozygotes can partially compensate through lifestyle choices that lower circulating insulin and IGF-1.

Specifically, time-restricted eating, intermittent fasting, and low-glycemic dietary patterns reduce insulin/IGF-1 signaling — the same pathway that determines the ratio of full-length to truncated FOXO3. Exercise (particularly resistance training and HIIT) activates FOXO3 through AMPK and SIRT1 pathways, providing an alternative route to FOXO3 activation that bypasses the need for the isoform regulatory advantage conferred by the C allele.

For those with the TT genotype, the metabolic associations from the Hussain 2022 data (higher glucose, higher HOMA-IR, elevated TNF-α and IL-6) suggest particular vigilance around insulin sensitivity and inflammatory markers.

Interactions

rs13217795 belongs to the primary FOXO3 longevity haplotype block together with rs2802292 and rs2764264. These three variants were discovered together in the original 2008 Willcox study and remain in partial linkage disequilibrium, particularly in Asian populations. However, they operate through distinct molecular mechanisms, meaning the effects are partially additive rather than entirely redundant.

The three-mechanism model for FOXO3 longevity: - rs2802292 (G allele): creates an HSF1 binding site → more FOXO3 transcription under stress - rs2764264 (C allele): removes an NKX3 repressor binding site → higher basal FOXO3 expression - rs13217795 (C allele): reduces FOXO3-TR truncated isoform → more functional FOXO3 protein per transcript

rs12206094 and rs4946935 (identified by Flachsbart et al. 2017) provide additional independent longevity signals through CTCF and SRF binding mechanisms, completing a picture of at least five functionally distinct regulatory elements contributing to FOXO3 expression and function across the human lifespan.